InnoCare Optoelectronics (6861) Q4 2024 earnings summary

Executive summary

• Revenue increased 9% year-over-year to NT$1,800.9 million, driven by growth in X-ray flat panel detector devices and modules.

• Net income rose 31% year-over-year to NT$152.9 million, with EPS of NT$3.75 (basic) and NT$3.64 (diluted).

• Gross margin improved to 23% from 22% year-over-year.

• The audit opinion was unqualified, with revenue recognition cutoff identified as a key audit matter.

Financial highlights

• Operating income was negative at NT$7.5 million, compared to negative NT$9.98 million last year.

• Total comprehensive income for the year was NT$123.7 million, up from NT$105.1 million.

• Cash and cash equivalents increased to NT$403.2 million from NT$342.8 million year-over-year.

• Total assets grew to NT$2,190.2 million, and equity rose to NT$1,383.2 million.

Outlook and guidance

• Proposed cash dividend for 2024 is NT$1.8 per share, pending shareholder approval.

• The company continues to invest in R&D and capital expenditures to support future growth.